| Financial Year |
March 31 2023 |
| Monetary Funds |
426,933,902.80 |
| Held-for-trading Financial Assets |
128,618,298.66 |
| Notes Receivable |
50,000.00 |
| Accounts Receivable |
294,169,230.65 |
| Advances to Suppliers |
3,784,019.87 |
| Other Receivables |
9,090,405.31 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
174,500,799.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,779,175.70 |
| Total Current Assets |
1,075,925,832.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
9,151,893.43 |
| Investment Properties |
-- |
| Fixed Assetes |
340,285,587.65 |
| Under-construction Projects |
376,095,215.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,331,831.98 |
| R&D expenses |
-- |
| Goodwill |
4,766,237.16 |
| Long-Term Deferred and Prepaid Expenses |
14,470,347.19 |
| Deferred Income Tax Assets |
5,224,884.31 |
| Other Non-Current Assets |
54,646,427.62 |
| Sub-Total of Non-Current Assets |
1,149,310,872.26 |
| Total Assets |
2,225,236,704.80 |
| Short-Term Loans |
74,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
115,686,024.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,175,663.98 |
| Taxes Payable |
19,022,375.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,112,239.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
31,506,884.53 |
| Other Current Liabilities |
835,571.86 |
| Sub-Total of Current Liabilities |
277,122,540.04 |
| Long-term Loans |
105,621,056.02 |
| Bonds Payable |
396,868,205.58 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
514,759.92 |
| Deferred Income Tax Liabilities |
8,792,734.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
568,898,204.72 |
| Total Liabilities |
846,020,744.76 |
| Paid-In Capital(Or Share Stock) |
502,507,912.00 |
| Capital Surplus |
140,610,565.27 |
| Surplus Reserve |
53,540,213.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
490,372,648.06 |
| Minority Stockholder's Interest |
48,434,514.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,330,781,445.08 |
| Owner's Equity（Stockholder's Equity） |
1,379,215,960.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,225,236,704.80 |
